METTL16 reduces the stability of PD-L1 mRNA via its m6A modification, consequently increasing the number of tumor-infiltrating immune cells in the immune microenvironment of cervical cancer, such as plasma cells and regulatory T cells [221]. Here, METTL16 is linked to cervical carcinoma.